Recent recommendations on steroid-induced osteoporosis: more targeted, but more complicated.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23376917.
- Also identified by DOI 10.3949/ccjm.80a.11094.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The latest recommendations for preventing and treating glucocorticoid-induced osteoporosis, published by the American College of Rheumatology (ACR) in 2010, incorporate developments that occurred since the release of its 2001 guidelines, such as new drugs and the World Health Organization's Fracture Risk Assessment Tool, or FRAX. They outline a more targeted approach but have the possible disadvantage of being more complicated and therefore harder to use.
Medical subject headings
- Bone Density Conservation Agents
- Fractures, Bone
- Glucocorticoids
- Osteoporosis